leisure time -WSS

leisure time

author：comprehensive 2025-10-01 21:09:59 - browse：5

SAN FRANCISCO — The small hotel meeting room was packed like a rush hour subway. Bankers in dark suits were crammed tightly into a small room on the third floor of the Westin St. Francis, lining the aisles and doorways, and spilling out into the hallways where it was impossible to hear.

The occasion: Nvidia, the chipmaker whose market capitalization has soared beyond $1 trillion because of its role in the revolutionary work occurring in artificial intelligence, was presenting at the J.P. Morgan Healthcare Conference, and describing why it thinks AI, running on Nvidia computers, could dramatically increase the number of new medicines that are created while reducing their cost, ushering in an age of “digital biology.”

When Kimberly Powell, Nvidia’s vice president of health care, finished her presentation, the room erupted in applause.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

hotspot

focus

WSS

More tobacco lobbyists active in statehouses

Emergent cuts jobs, executive role in business shake

Why failed clinical trials don’t always spell doom for a new drug

A biotech analyst on neuroscience, placebo effect, not over

South Korea throws huge K

Anavex keeps shifting the goalposts in its clinical trials

focus

leisure time

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Naloxone nonprofit donates 200,000 doses after FDA approval

How to save PrEP access — and even expand it

For Cytokinetics, FDA rejection of heart drug would help, not hinder

As demand for Covid shots wanes, Moderna seeks its next success

Wegovy trial has doctors encouraged over new possibilities

How to save PrEP access — and even expand it

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Anavex keeps shifting the goalposts in its clinical trials

focus

Why rehabilitation engineers need to center patients in their research

Dogs on Prozac: What pet anti

South Korea throws huge K

How to use technology to prevent future drug shortages

Drastic changes should bring profitability, startup health insurers say

Medical bills so high, Medicare adding extra digits to claim forms

Wikipedia

hotspot

focus

knowledge